Canaccord Genuity Cuts Price Target on Abaxis (ABAX) Following Veterinarian Survey
Tweet Send to a Friend
Canaccord Genuity reiterated a Buy rating on Abaxis Inc. (NASDAQ: ABAX), and cut the price target to $62.00 (from $68.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
